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Naproxen affects osteogenesis of human
mesenchymal stem cells via regulation of
Indian hedgehog signaling molecules
Omar Salem1, Hong Tian Wang1, Abdulrahman M Alaseem1, Ovidiu Ciobanu1, Insaf Hadjab1,3, Rahul Gawri1,4,5,
John Antoniou1,2 and Fackson Mwale1,2*
Abstract
Introduction: We previously showed that type X collagen, a marker of late stage chondrocyte hypertrophy
(associated with endochondral ossification), is constitutively expressed by mesenchymal stem cells (MSCs) from
osteoarthritis patients and this may be related to Naproxen (Npx), a nonsteroidal anti-inflammatory drug used for
therapy. Hedgehog (HH) signaling plays an important role during the development of bone. We tested the hypothesis
that Npx affected osteogenic differentiation of human MSCs through the expression of Indian hedgehog (IHH),
Patched-1 (PTC1) and GLI family members GLI1, GLI2, GLI3 in vitro.
Methods: MSCs were cultured in osteogenic differentiation medium without (control) or with 0.5 μM Npx. The
expression of collagen type X, alpha 1 (COL10A1), alkaline phosphatase (ALP), osteopontin (OPN), osteocalcin (OC),
collagen type I, alpha 1 (COL1A1) was analyzed with real-time reverse transcription (RT) PCR, and the ALP activity was
measured. The osteogenesis of MSCs was monitored by mineral staining and quantification with alizarin red S. To
examine whether Npx affects osteogenic differentiation through HH signaling, the effect of Npx on the expression of
IHH, GLI1, GLI2, GLI3 and PTC1 was analyzed with real-time RT PCR. The effect of cyclopamine (Cpn), a HH signaling
inhibitor, on the expression of COL10A1, ALP, OC and COL1A1 was also determined.
Results: When MSCs were cultured in osteogenic differentiation medium, Npx supplementation led to a significant
decrease in ALP gene expression as well as its activity, and had a tendency to decrease mineral deposition. It also
decreased the expression of COL1A1 significantly. In contrast, the gene expression of COL10A1 and OPN were
upregulated significantly by Npx. No significant effect was found on OC expression. The expression of IHH, PTC1, GLI1,
and GLI2 was increased by Npx, while no significant difference was observed on GLI3 expression. Cpn reversed the
effect of Npx on the expression of COL10A1, ALP, OPN and COL1A1.
Conclusions: These results indicate that Npx can affect gene expression during osteogenic differentiation of MSCs,
and downregulate mineral deposition in the extracellular matrix through IHH signaling. Therefore, Npx could affect
MSC-mediated repair of subchondral bone in OA patients.
Introduction
Symptomatic osteoarthritis (OA), characterized by cartil-
age deterioration and osteophyte formation, is the most
common joint disorder, affecting primarily the knees,
hips, and hands, and the predominant symptom is pain
[1]. It is the major reason for seeking medical care and
accounts for most of the use of non-steroidal anti-
inflammatory drugs (NSAIDs) [2]. Clinical recommenda-
tions for the sympathetic treatment of OA include acet-
aminophen (Acet) and NSAIDs such as ibuprofen (Ibu),
diclofenac (Dic), naproxen (Npx), and celecoxib (Cele)
[3]. Unlike narcotics that target the central nervous sys-
tem to alleviate pain, NSAIDs inhibit cyclooxygenase
(COX) activity within the central nervous system and at
the peripheral pain site to prevent the conversion of
arachidonic acid into prostaglandins. Thus, NSAIDs
can alter certain fundamental processes involved in the
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http://arthritis-research.com/content/16/4/R152normal healing of injured tissues [4]. However, they are
often inadequate and pain is the number one reason for
undergoing joint replacement surgery [5].
Subchondral bone sclerosis and progressive cartilage
degradation are widely considered as the hallmarks of
OA. Despite the increase in bone volume fraction, sub-
chondral bone is hypomineralized due to abnormal bone
remodeling [6,7]. NSAIDs are used clinically to prevent
ectopic bone formation that is also known as heterotopic
ossification, and the efficacy of NSAIDs in the avoidance
of heterotopic ossification has been documented in con-
trolled clinical trials. Experimental studies also have doc-
umented the negative effects of NSAIDs on healing of
skeletal tissues [8]. In earlier work, it was found that
NSAIDs suppressed proliferation and induced cell death
in cultured osteoblasts [9]. However, little is known
about their effects on the subchondral bone repair in
OA patients.
Mesenchymal stem cells (MSCs) are multipotent
stromal cells capable of differentiating into multiple
mesenchymal lineages, including osteogenic, chondro-
genic, adipogenic, myogenic, and neurogenic lineages,
under different conditions [10,11]. MSCs can differ-
entiate to osteoblasts to form bone, while commit-
ment of osteoprogenitor cells and differentiation into
pre-osteoblasts, which eventually develop into mature
osteoblasts, is a requisite [12]. To reverse or retard
the degeneration of articular cartilage and repair the sub-
chondral bone, MSCs can be employed in biological ther-
apy for OA [13].
In the previous study, we found that NSAIDs can
affect the expression of both hypertrophic and osteo-
genic genes in MSCs during expansion, and naproxen
(Npx) showed a stronger effect on gene expression in
MSCs than other drugs [14]. The effect of the drugs on
gene expression in MSCs can influence the treatment of
OA. Thus, it is important to understand whether Npx
affects the osteogenesis of MSCs.
The Hedgehog (HH) protein family has been found
in all vertebrates, since their original discovery in Dros-
ophila. Indian hedgehog (IHH) regulates both chondro-
genesis and endochondral bone formation [15,16]. It
is known to stimulate bone formation via a positive
feedback loop. Disruption of HH signaling results in
severe skeletal abnormalities [17]. HH morphogens
are secreted from the cells and bind to the receptor,
Patched (PTC), to relinquish SMO from PTC suppres-
sion, thereby enabling activation of the GLI family of
transcription factors, which are used as markers for
HH signaling activity [18,19]. They are responsible for
HH-induced lineage commitment during MSC differ-
entiation [20,21].
In this research, the effect of Npx on hypertrophy
and osteogenesis of MSCs was studied. Because IHHsignaling can affect the osteogenesis of MSCs and
other osteogenesis-related signaling pathways [21-23], the
effect of Npx on IHH signaling was also studied to eluci-
date the mechanisms involved.
Materials and methods
Source and expansion of stem cells
Normal human MSCs were obtained from Lonza
Walkersville Inc (Walkersville, MD, USA). According to
the supplier, these cells were harvested from healthy hu-
man bone marrow and were positive for CD105, CD166,
CD29 and CD44, but negative for CD14, CD34 and
CD45. All cells were expanded in DMEM supplemented
with 10% FBS, 100 U/mL penicillin, and 100 μg/mL
streptomycin and were used within four passages. The
culture medium and the supplement were from Wisent
Inc (St-Bruno, QC, Canada).
Cell culture
In every well of a six-well plate (Sarstedt, QC, Canada),
5 × 105 MSCs were plated and cultured in expansion
medium overnight. The floating cells were removed and
the attached cells were cultured until the confluence was
more than 90%. Then the cells were cultured in osteo-
genic differentiation medium for 3 days to allow the cells
to adapt to the new environment. Afterwards, the cells
were cultured in 3 mL/well of osteogenic differentiation
medium with 0.5 μM Npx (Sigma-Aldrich, Oakville,
ON, Canada). The cells cultured without Npx were used
as control cells. To test the effect of cyclopamine (Cpn)
on gene expression in MSCs, 0.5 μM cyclopamine
(Sigma-Aldrich) was dissolved in the culture medium.
The osteogenic differentiation medium was prepared
with high-glucose DMEM containing 10% FBS, 0.1 μM
dexamethasone, 10 mM β-glycerophosphate, 50 μM
L-ascorbic acid, 100 units/mL penicillin, and 100 μg/mL
streptomycin.
Total RNA isolation
After MSCs were cultured for 3, 6 and 12 days, they were
washed with PBS and total RNA was extracted using Trizol
reagent (Invitrogen, Burlington, ON, Canada) according to
the protocol from the supplier [11,14].
Reverse transcription and real-time PCR
First, 1 μg total RNA isolated from the cells was digested
with DNase I (Invitrogen) according to the protocol of
the supporter. Then, the purified RNA was reverse-
transcribed as described previously [11,14]. Briefly, 1 μg
RNA was mixed with random primers (final concen-
tration 0.15 μg/μL), dNTP mixture (final concentra-
tion 0.5 mM), and DEPC-treated distilled water with a
total volume of 12 μL. After the solution was incubated
at 65°C for 5 minutes, it was mixed with a first-strand
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reverse transcriptase with a final volume of 20 μL.
Then, the solution was incubated at 45°C for 50 mi-
nutes to perform the reverse transcription and then at
70°C for 15 minutes to inactivate the reverse tran-
scriptase. For LightCycler real-time PCR, a master mix
of the following reaction components was prepared
with the final concentrations at 10 μL SYBER PCR
master mix (Qiagen, Mississauga, ON, Canada), 8 μL
distilled water, 0.5 μL forward primer (final concentra-
tion 0.25 μM), and 0.5 μL reverse primer (final con-
centration 0.25 μM). To each 19 μL master mix, 1 μL
of cDNA was mixed as a PCR template. The sequences
of primers are in Table 1. The reaction conditions in-
cluded one cycle of PCR initial activation step (95°C for
15 minutes, 20°C/s ramp rate), 45 cycles of amplification
and quantification (94°C for 15 s, 57°C for 30 s, 72°C
for 30 s), one cycle of melting curve (65°C to 95°C with
heating rate of 0.1°C/s with a continuous fluorescence
measurement), and a final cooling step to 4°C.
The crossing points (CPs) were determined by the
Light-Cycler software 3.3 (Roche Diagnostics, Indianapolis,
IN, USA) and were measured at constant fluorescence
level. The ratio of gene expression relative to GAPDHTable 1 Primer sequences
Gene Sequence Size (bp)
ALP Forward (1397–1416): CCACGTCTTCACATTTGGTG 196
Reverse (1573–1592): AGACTGCGCCTGGTAGTTGT
COL1A1 Forward (3982–4001): GAGAGCATGACCGATGGATT 178
Reverse (4140–4159): CCTTCTTGAGGTTGCCAGTC
COL10A1 Forward (1670–1690): AATGCCTGTGTCTGCTTTTAC 130
Reverse (1779–1799): ACAAGTAAAGATTCCAGTCCT
GAPDH Forward (113–133): TGAAGGTCGGAGTCAACGGAT 181
Reverse (273–293): TTCTCAGCCTTGACGGTGCCA
GLI1 Forward (676–695): AAGCGTGAGCCTGAATCTGT 189
Reverse (845–864): CAGCATGTACTGGGCTTTGA
GLI2 Forward (199–218): CGACACCAGGAAGGAAGGTA 203
Reverse (382–401): TGCACAGAACGGAGGTAGTG
GLI3 Forward (2285–2304): CTTTGCAAGCCAGGAGAAAC 163
Reverse (2428–2447): TTGTTGGACTGTGTGCCATT
IHH Forward (519–538): CGGCTTTGACTGGGTGTATT 219
Reverse (718–737): AAAATGAGCACATCGCTGAA
OC Forward (20–39): TGAGAGCCCTCACACTCCTC 151
Reverse (170–151): CGCCTGGGTCTCTTCACTAC
OPN Forward (759–778): TGAAACGAGTCAGCTGGATG 162
Reverse (920–901): TGAAATTCATGGCTGTGGAA
PTC1 Forward (1460–1479): TCAGCAATGTCACAGCCTTC 248
Reverse (1688–1707): GTCGTGTGTGTCGGTGTAGGas the reference gene was determined by the following
equation [11,14]:
Relative ratio ¼ 2
ΔCPtarget control−sampleð Þ
2ΔCPreference control−sampleð Þ
Alkaline phosphatase activity
After MSCs were cultured in osteogenic differenti-
ation medium with or without Npx for 3, 6, and 12
days, the cells were lysed and ALP activity was assayed
with StemTAG™ Alkaline Phosphatase Activity Assay Kit
(Colorimetric) (Cell Biolabs Inc, San Diego, CA, USA)
according to the protocol from the supplier.
Mineralization analysis with alizarin red S
Osteogenic differentiation was monitored by mineral
deposition with alizarin red S staining as previously
described [11]. To quantify the matrix mineralization,
alizarin red S was extracted with 1 mL/well 100 mM
cetylpyridinium chloride (Sigma-Aldrich) and measured
at 570 nm.
Statistical analysis
Statistical analysis was performed using one-way
analysis of variance (ANOVA), followed by Fisher’s
protected least significant difference post hoc test,
using Statview (SAS Institute, Inc). The results of
three experiments with MSCs from three different
donors were assessed, and the values were reported
as mean ± SD. The significance was defined as a
P-value <0.05.
Results
Message expression for various matrix protein genes was
analyzed after culturing MSCs in osteogenic conditions
supplemented with or without Npx for 3, 6 and 12 days.
COL10A1 is a marker gene for hypertrophic chondrocyte
differentiation [24,25]. At day 6, the COL10A1 message
was increased significantly with Npx supplementation in
the culture medium (P = 0.007), while no significant dif-
ference was found at days 3 and 12 (Figure 1A). Alkaline
phosphatase (ALP), osteopontin (OPN), osteocalcin (OC)
and COL1A1 are important genes that define the osteo-
genesis of MSCs [24-26]. To test the effect of Npx on
osteogenesis of MSCs, the expression of these genes was
examined after MSCs were cultured in osteogenic differ-
entiation medium with or without Npx for 3, 6 and
12 days. When MSCs were cultured with Npx for 6 and
12 days, message levels of ALP were decreased sig-
nificantly compared with control (P = 0.007 on day 6;
P = 0.001 on day 12), while no significant difference was
observed on day 3 (Figure 1B). Npx increased OPN ex-
pression significantly on day 6 (P = 0.006) and day 12
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Figure 1 Relative ratio of COL10A1 (A), ALP (B), OPN (C), OC (D) and COL1A1 (E) gene expression in mesenchymal stem cells (MSCs)
cultured in osteogenic differentiation medium without (control) or with 0.5 μM naproxen (Npx). The expression of COL10A1 was detected
after the cells were cultured for 3, 6 and 12 days. The results are shown as mean ± SD of three independent experiments with MSCs isolated
from three different donors. *P <0.05 versus control; **P <0.01 versus control; ***P <0.001 versus control.
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was observed on day 3 (Figure 1C). Treatment with
Npx did not result in a significant change in OC ex-
pression (Figure 1D). Npx decreased the expression of
COL1A1 significantly on day 6 (P = 0.013) and day 12
(P = 0.007), while no significant effect was observed on
day 3 (Figure 1E).
As Npx suppressed ALP gene expression (Figure 1B), we
next tested the effect of Npx on ALP activity (Figure 2).
Npx significantly decreased ALP activity when MSCs were
cultured with Npx for 6 days (P = 0.03) and 12 days
(P = 0.004), but did not significantly decrease ALP activity
on day 3 (Figure 2).
In order to verify that MSC cultured in osteogenic
differentiation medium with Npx for 21 days results
in the deposition of mineral, they were visualized by
staining the cells with alizarin red S, which detects
calcium deposition. Red staining was present through-
out the cultures (Figures 3A,B). With Npx, there appeared
to be a decrease in the extent of matrix mineralization.
When alizarin red S was extracted from the matrix,mineral deposition in the presence of Npx decreased
although not significantly compared with control cells
(Figure 3C).
IHH signaling is an important pathway in osteogenic
differentiation, and is defined by IHH, GLI1, GLI2, GLI3
and PTC1 genes [18,19]. The effect of Npx on the ex-
pression of these genes was therefore assessed. When the
cells were cultured in osteogenic differentiation medium
with Npx, the expression of IHH increased significantly on
day 6 (P <0.001) and day 12 (P = 0.006) compared with
that in control cells (Figure 4A). This difference was not
observed on day 3. The expression of PTC1 (P = 0.006),
GLI2 (P = 0.005) increased significantly on day 12 com-
pared with that in control cells (Figure 4B,D), while the
expression of GLI1 increased significantly on both day 3
(P = 0.001) and day 12 (P = 0.003) (Figure 4C). No
significant effect of Npx on the expression of GLI3 was
observed (Figure 4D).
Cpn can downregulate HH signaling pathway activity
by binding directly to SMO, a key component of the HH
signaling pathway [27,28]. To determine whether the
Figure 3 Effect of naproxen (Npx) on mineral deposition by mesenchym
Alizarin red S staining of mineral deposition in the extracellular matrix aft
(control) (A) or with 100 μg/mL Npx (B) for 21 days (bar represents 50 μm
570 nm. The results are shown as mean ± SD of three independent expe
determined as statistically significant.
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Figure 2 The activity of alkaline phosphatase (ALP) in
mesenchymal stem cells (MSCs) cultured in osteogenic
differentiation medium without (control) or with 0.5 μM
naproxen (Npx) for 3, 6 and 12 days. The results are shown as
mean ± SD of three independent experiments with MSCs isolated
from three different donors. *P <0.05 versus control; **P <0.01
versus control.
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and COL1A1 was directly through the HH signaling
pathway, MSCs were cultured in osteogenic differenti-
ation medium with Npx alone or both Npx and Cpn. On
day 6, the expression of COL10A1 with cyplocamine
supplementation decreased significantly compared with
Npx alone (P = 0.04) (Figure 5A). ALP expression was
increased significantly with Cpn supplementation com-
pared with Npx alone on day 6 (P = 0.003) and day 12
(P = 0.002) (Figure 5B). Compared with Npx alone, the
expression of OPN was decreased significantly by Cpn on
both day 6 (P <0. 001) and day 12 (P = 0.007) (Figure 5C).
The expression of COL1A1 was upregulated by Cpn on
day 6 (P = 0.002) and day 12 (P = 0.04). The significant dif-
ference was not observed for either COL10A1 (Figure 5A)
or ALP (Figure 5B) expression with Cpn supplemen-
tation on day 12. Thus Npx appeared to affect the ex-
pression of COL10A1, ALP, OPN and COL1A1 through
HH signaling in MSCs. Preliminary studies showed that
Cpn alone had no effect on COL10A1, ALP, OPN and
COL1A1 expression (data not shown), and because the
results of culturing MSCs in osteogenic differentiation
medium alone were conducted in Figure 1, these were not
included in order to simplify the figures.al stem cells (MSCs) cultured in osteogenic differentiation medium.
er MSCs were cultured in osteogenic differentiation medium without
); (C) the absorbance value of solubilized alizarin red S measured at
riments with MSCs isolated from three different donors. P <0.05 was
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Figure 4 The relative ratio of IHH (A), PTC1 (B), GLI1 (C), GLI2 (D) and GLI3 (E) expression in mesenchymal stem cells (MSCs) cultured in
osteogenic differentiation medium without (control) or with 0.5 μM naproxen (Npx) for 3, 6, and 12 days. The results are shown as
mean ± SD of three independent experiments with MSCs from three different donors. **P <0.01 versus control; ***P <0.001 versus control.
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If MSCs are to be used to stimulate bone repair in the
presence of NSAIDs in the synovial fluid, it is essential
that NSAIDs do not interfere with osteogenic differen-
tiation. The results of the present work indicate that
Npx can induce the expression of COL10A1 and OPN,
and downregulate the expression of ALP and COL1A1
through activation of HH signaling. The downregula-
tion of ALP gene expression led to the suppression of its
activity and decreased mineral deposition. Osteogenesis
occurs through an endochondral process involving cellu-
lar hypertrophy and mineralization in a manner analo-
gous to the growth plate. Type X collagen is a marker of
hypertrophy, whereas ALP, OC, OPN and COL1A1 are
bone matrix proteins synthesized by osteoblasts [24-26].
Mineralization is a functional endpoint reflecting advanced
osteogenesis. Achieving increased expression of OC, OPN,
COL1A1, as well as ALP activity and mineralization istherefore an essential requisite for bone repair. Thus
Npx has the potential to interfere with MSCs in repairing
bone.
The effect of anti-inflammatory drugs on the osteo-
genesis of MSCs has been reported previously in other
studies. It was reported that the osteogenic potential
of MSC is inhibited/delayed by treatment with high-
dose NSAIDs under inflammatory conditions, while no
significant effects were observed in non-inflammatory-
conditioned MSCs [29]. In another experiment, it was
reported that NSAIDs can inhibit bone formation via
blockage of MSC chondrogenic differentiation - an im-
portant intermediate phase in normal endochondral
bone formation - but not the osteogenesis of MSC [30]. In
our study, Npx had a tendency to downregulate matrix
mineralization. Furthermore, its effect on the expression of
OPN and COL1A1 could affect the function of bone. In
addition to their effects on osteogenesis, high-dose and
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Figure 5 The effect of the Hedgehog (HH) signaling pathway inhibitor cyclopamine (Cpn) on the expression of COL10A1 (A), ALP (B),
OPN (C) and COL1A1 (D) in mesenchymal stem cells (MSCs) cultured in osteogenic differentiation medium with 0.5 μM naproxen (Npx)
for 6 and 12 days. The results are shown as mean ± SD of three independent experiments with MSCs from three different donors. *P <0.05;
**P <0.01 cells cultured with both cyclopamine (Cpn) and naproxen (Npx) versus cells cultured with Npx only.
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induce adipogenesis in stem cells. For instance, Indometh-
acin can stimulate adipogenesis of MSCs [31]. However,
the effect of Npx on adipogenesis is not known. Interest-
ingly, Npx was shown to have anti-obesity effects in ani-
mals when injected at a high dose [32].
A decrease in the expression of osteogenic markers
and functional mineralization, and an increase in the
expression of hypertrophic chondrocyte markers was
observed after prolonged culture with Npx. During
hypertrophy, cells enlarge in many tissues such as the
growth plate, muscle and cartilage, which also occurs in
conditions of degeneration, such as OA. However, we did
not observe any appreciable increase in cell volume. It has
been reported that calcium/calmodulin-dependent kinase
II (CamkII) is an essential component of intracellular sig-
naling pathways regulating chondrocyte maturation, and it
can induce cell hypertrophy through a branched set of ef-
fector pathways including the transcriptional regulators
Runx2 and Mef2c [33,34]. Activation of CamkII activity
can result in premature hypertrophic gene expression,
with no cell swelling. Furthermore, chondrocytes can dis-
play morphological changes consistent with hypertrophy,
without upregulating the expression of hypertrophic genes[33,34]. Thus, the hypertrophic program may be more
complex than previously thought.
Npx affected the expression of IHH, PTC1, GLI1 and
GLI2 genes belonging to the HH signaling pathway, and
affected the expression of osteogenic genes in MSCs at
different time points. This might be the result of the
interaction of different proteins involved in HH signaling
[22]. The upregulation of IHH, GLI1 and GLI2 can in-
crease the HH signaling pathway positively, while the
upregulation of PTC1 has a negative effect on the HH
signaling function as more IHH molecules will interact
with increased PTC1 and result in less SMO being re-
leased. As Npx did not affect the expression of GLI3, it
is possible that GLI3 does not play a direct role in the
osteogenesis of MSCs. Interestingly, we were unable to
detect the expression of Sonic Hedgehog (SHH), another
gene involved in HH signaling and osteogenesis of
MSCs, with primers that were specific for human SHH.
The bone repair process in adults resembles normal
development of the skeleton during embryogenesis. Nu-
merous signaling pathways induce the osteogenic differ-
entiation of MSCs. Although the mechanisms have not
been fully discerned, and only HH signaling was studied
in this research, other signaling pathways may also affect
Salem et al. Arthritis Research & Therapy 2014, 16:R152 Page 8 of 9
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cate that Npx can affect treatment and lineage differenti-
ation of MSC through the IHH signaling pathway, a
better understanding of these underlying mechanisms
and the effect of other NSAIDs on the osteogenesis of
MSCs have far-reaching implications for improving bone
repair for OA treatment.
Conclusions
The results support the concept that Npx has a dual role
in that it can stimulate hypertrophic differentiation of
MSCs, while suppressing osteogenic differentiation of
MSCs and mineral deposition in the matrix through HH
signaling.
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